Angiosarcoma of the scalp responding to nivolumab: a case report-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Angiosarcoma of the scalp responding to nivolumab: a case report

Published:2018-06-13 Issue: Volume: Page:
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Hofer S.¹^ORCID,Zeidler K.¹,Schipf A.²,Kempf W.³⁴,Zimmermann D.⁵,Aebi S.¹

Affiliation:

1. Division of Medical Oncology

2. Department of Pathology; Luzerner Kantonsspital; Luzern 6000 Switzerland

3. Pathology Kempf & Pfalz; Zürich Switzerland

4. Department of Dermatopathology

5. Institute of Molecular Pathology; University Hospital Zürich; Zürich Switzerland

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjd.16698/fullpdf

Reference7 articles.

1. Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial;Tawbi;Lancet Oncol,2017

2. Angiosarcoma treated successfully with anti-PD-1 therapy - a case report;Sindhu;J Immunother Cancer,2017

3. Temporal and spatial discordance of programmed cell death-ligand 1 expression and lymphocyte tumor infiltration between paired primary lesions and brain metastases in lung cancer;Mansfield;Ann Oncol,2016

4. A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy;Łuksza;Nature,2017

5. T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas;Pollack;Cancer,2017

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ipilimumab and nivolumab: the ‘new kid on the block’ in advanced angiosarcoma;Immunotherapy;2023-10

2. Cadonilimab plus anlotinib effectively relieve rare cardiac angiosarcoma with multiple metastases: a case report and literature review;Clinical Research in Cardiology;2023-07-05

3. Tumor immune microenvironment of cutaneous angiosarcoma with cancer testis antigens and the formation of tertiary lymphoid structures;Frontiers in Oncology;2023-04-04

4. Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART);Journal for ImmunoTherapy of Cancer;2021-08

5. Tertiary lymphoid structures correlate with better prognosis in cutaneous angiosarcoma;Journal of Dermatological Science;2021-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3